Phase I/II MR Guided Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer
Summary
This research study is for people who have pancreas cancer for which surgery is not recommended. Potential patients must have already received several months of chemotherapy before they are eligible for this study and there will not have been any detectable spread of their tumor on imaging studies following this chemotherapy course.
General Information
NCT#: NCT01972919
Study ID: MCW-17687
Trial Phase: Phase II
Trial Sponsor: Medical College of Wisconsin
Therapies Used in This Trial: Gemcitabine, Radiation Therapy, Capecitabine